McKesson completed the acquisition of a 70% stake in Community Oncology Revitalization Enterprise Ventures from Florida Cancer Specialists & Research Institute for $2.49bn.

McKesson, a company that distributes pharmaceuticals and provides health information technology, completed the acquisition of a 70% stake in Community Oncology Revitalization Enterprise Ventures, a business and administrative services organization, from Florida Cancer Specialists & Research Institute, an independent medical oncology practice, for $2.49bn. The acquisition advances community-based oncology care and enables McKesson to continue to accelerate clinical development, improve patient outcomes, and expand access to quality cancer care in local communities.